Visceral Leishmaniasis
-10%
portes grátis
Visceral Leishmaniasis
Therapeutics and Vaccines
Kumar, Awanish
Elsevier Science & Technology
05/2021
158
Mole
Inglês
9780323911245
15 a 20 dias
270
Descrição não disponível.
1. Visceral leishmaniasis: An overview 2. Maintenance of Leishmania parasite 3. Host immunity and immunomodulation 4. VL and natural products 5. Antileishmanial drug screening 6. Vaccine and Vaccination 7. Different vaccination approaches for development of vaccine 8. Adjuvants 9. Vaccine delivery system 10. Routes of vaccination 11. Animal models for VL 12. Vaccination approaches for VL 13. Current status in Leishmania vaccine and problems to be solved 14. Amastigote based vaccine: Silver lining in Leishmaniasis
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Action; Activity; Adjuvants; Amastigote; Amastigote-based vaccine; Animal model; Antileishmanial; Antileishmanials; Approaches; Assays; Attenuated strains; Bacterial ghost; Burden; Chemotherapy; Classification; Conjugate; Culture; Current status; Design; Development; Drug candidate; Efficacious; Evolution; Formulations; Host; Hypothesis; Immune response; Immunomodulators; In vivo; Inactivated vaccines; Intradermal; Intramuscular; Intranasal; Leishmania; Leishmania parasite; Leishmaniasis; Liposome; Live attenuated vaccines; Mechanism; Methods; Natural product; Oral; Plasmid/vectors; Promastigote; Promastigote antigen; Promising approach; Recombinant; Recombinant/Subunit vaccines; Safe; Screening; Selection; Specific, immunomodulation; Subcutaneous; Toxicoid; Types; Vaccination; Vaccinations; Vaccine; Vaccine candidate; Vaccine generations; Virosome; Visceral leishmania; VL; VL control
1. Visceral leishmaniasis: An overview 2. Maintenance of Leishmania parasite 3. Host immunity and immunomodulation 4. VL and natural products 5. Antileishmanial drug screening 6. Vaccine and Vaccination 7. Different vaccination approaches for development of vaccine 8. Adjuvants 9. Vaccine delivery system 10. Routes of vaccination 11. Animal models for VL 12. Vaccination approaches for VL 13. Current status in Leishmania vaccine and problems to be solved 14. Amastigote based vaccine: Silver lining in Leishmaniasis
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Action; Activity; Adjuvants; Amastigote; Amastigote-based vaccine; Animal model; Antileishmanial; Antileishmanials; Approaches; Assays; Attenuated strains; Bacterial ghost; Burden; Chemotherapy; Classification; Conjugate; Culture; Current status; Design; Development; Drug candidate; Efficacious; Evolution; Formulations; Host; Hypothesis; Immune response; Immunomodulators; In vivo; Inactivated vaccines; Intradermal; Intramuscular; Intranasal; Leishmania; Leishmania parasite; Leishmaniasis; Liposome; Live attenuated vaccines; Mechanism; Methods; Natural product; Oral; Plasmid/vectors; Promastigote; Promastigote antigen; Promising approach; Recombinant; Recombinant/Subunit vaccines; Safe; Screening; Selection; Specific, immunomodulation; Subcutaneous; Toxicoid; Types; Vaccination; Vaccinations; Vaccine; Vaccine candidate; Vaccine generations; Virosome; Visceral leishmania; VL; VL control
